Rephonic
Artwork for tHEORetically Speaking

tHEORetically Speaking

HealthEconomics.com
Market Access
Real World Evidence
Real World Data
Artificial Intelligence
Covid-19
Health Economics
Real-World Data
Data Harmonization
Electronic Medical Records
Healthcare Research
EU HTA
Joint Clinical Assessment
FDA
Oncology
Data Quality
Healthcare
Pharmaceutical
Health Technology Assessments
Pricing Strategies
AI In Pharma

Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: healtheconomics.com/theoretically-speaking/

PublishesWeeklyEpisodes55Founded3 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for tHEORetically Speaking

Latest Episodes

This week’s tHEORetically Speaking News Roundup covers the CDC’s ACIP meeting and its implications for U.S. vaccine policy, GHO Capital’s acquisition of AI-powered R&D platform Scientist.com, and GSK’s $30 billion investment in U.S. drug manufacturin... more

This week’s tHEORetically Speaking News Roundup covers new research on social-genetic influences in adolescent depression, Novartis’s $1.4B acquisition of Tourmaline Bio for a promising heart drug, and encouraging Phase 2 results for rezatapopt in so... more

This week’s tHEORetically Speaking News Roundup covers Novo’s Wegovy showing superior cardiovascular benefits over Lilly’s Zepbound, the FDA’s new Rare Disease Evidence Principles to accelerate ultra-rare drug development, and Florida’s move to aboli... more

This week’s tHEORetically Speaking News Roundup covers DaVita’s massive ransomware attack impacting 2.7 million patients, the FDA’s updated COVID-19 booster approvals for high-risk groups, and Roche’s $700M investment in a new obesity drug facility i... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Pharma Sessions
Pharma SessionsJonathan Kaskey

Recent Guests

Matt McLoughlin
Senior Vice President for Compliance and Categories at scientists.com, with over 25 years in the pharmaceutical industry, including experience as a geneticist for AstraZeneca.
scientists.com
Episode: INsights & OUTcomes with Matt McLoughlin
Catherine Bacon
Founder of FingerPost Consulting, with over 15 years of experience in market access.
FingerPost Consulting
Episode: INsights & OUTcomes with Catherine Bacon
Dr. Vernon Schabert
Founder of Epilogix with over 28 years of experience in health economics and pharmacopidemiology.
Epilogix
Episode: INsights & OUTcomes with Vernon Schabert
Rosa Willock
Senior Consultant at Decisive Consulting, with experience in RWE research and project delivery.
Decisive Consulting
Episode: INsights & OUTcomes with Rosa Willock
Chris O'Neill
Founder and CEO of Bosun Market Access, author of "Fast Track to Success"
Bosun Market Access
Episode: INsights & OUTcomes with Chris O'Neill

Hosts

Sarah McFarlane
Host of Theoretically Speaking who discusses topics related to health economics and market access, facilitating conversations that intersect data with decision-making.
Paige McGarry
Associate HUR, RWE and Market Access Category Manager at scientists.com, often discussing insights on real-world evidence integration in healthcare.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

INsights & OUTcomes with Chris O'Neill
Q: How do you currently see AI being used in strategic development, particularly within healthcare organizations?
O'Neill highlights the effectiveness of AI in areas such as drug discovery, clinical trial design, and personalized medicine, but also notes its potential is underutilized in strategic contexts.
INsights & OUTcomes with Chris O'Neill
Q: Can you share briefly about your current role and what your journey has looked like thus far?
O'Neill discusses his transition from a general consultant to founding Bosun Market Access and emphasizes a focus on providing strategic direction in market access through innovative solutions, particularly the use of AI.
INsights & OUTcomes with Vernon Schabert
Q: How can we better capture the unexpected use of drugs by providers and patients when evaluating product effectiveness in real world settings?
Dr. Schabert suggests viewing real world data as a piece of marble, where researchers need to appreciate existing behaviors and decisions in the data to effectively understand and analyze it.
INsights & OUTcomes with Vernon Schabert
Q: How do you see the demand for real world data changing over the next few years?
Dr. Schabert notes that there's a lot of attention on regulatory applications of RWD, but growth may not significantly come from those areas once the initial marketing wave subsides.
tHEORetically Speaking: Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner
Q: What common challenges do biotechs face in the transition from clinical development to commercialization?
Biotechs often struggle to shift from being science-focused to understanding market needs, revenue generation, and integrating their clinical data with commercial strategies effectively.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About tHEORetically Speaking

What is tHEORetically Speaking about and what kind of topics does it cover?

Focused on the intersection of health care, data, and value-based decision-making, this series provides insights and perspectives on the evolving landscape of health economics and outcomes research. Notable topics include the integration of real-world evidence in clinical practice, market access strategies, and the implications of regulatory changes in healthcare. Key highlights often feature significant industry developments, advancements in health technology, and discussions about empowering professionals within the health sector. The format likely attracts listeners interested in healthcare innovation, regulatory updates, and insights from industry leaders to navigate challenges in the pharmaceutical and life sciences fields.

Where can I find podcast stats for tHEORetically Speaking?

Rephonic provides a wide range of podcast stats for tHEORetically Speaking. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to tHEORetically Speaking and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does tHEORetically Speaking get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for tHEORetically Speaking, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for tHEORetically Speaking?

Rephonic provides comprehensive predictive audience data for tHEORetically Speaking, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does tHEORetically Speaking have?

To see how many followers or subscribers tHEORetically Speaking has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to tHEORetically Speaking?

These podcasts share a similar audience with tHEORetically Speaking:

1. Pharma Sessions

How many episodes of tHEORetically Speaking are there?

tHEORetically Speaking launched 3 years ago and published 55 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact tHEORetically Speaking?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for tHEORetically Speaking?

Rephonic pulls ratings and reviews for tHEORetically Speaking from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for tHEORetically Speaking?

Rephonic provides full transcripts for episodes of tHEORetically Speaking. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on tHEORetically Speaking?

Recent guests on tHEORetically Speaking include:

1. Matt McLoughlin
2. Catherine Bacon
3. Dr. Vernon Schabert
4. Rosa Willock
5. Chris O'Neill

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days